Latest Industry News & Trends

Market Scope provides comprehensive coverage of the ophthalmic market. Our news stories are a combination of public and proprietary content ranging from coverage of international meetings, surgeon survey results and trends, analysis of company financial reports and public medical registries, press releases, and interviews with companies executive. Register today to receive free weekly email updates, our top data chart, surgeon poll results, and much more. Locked content can be accessed through a subscription to our ophthalmic industry newsletters.

Recently Added News

11/24/2021
BreakingClinical TrialPharmaRetina
Oculis Doses First Patients in Phase III Trial of DME Drop
Oculis Doses First Patients in Phase III Trial of DME Drop

Swiss company Oculis announced Nov. 12 that the first patients had been dosed in its Phase III DIAMOND trial evaluating OCS-01 in diabetic macular edema (DME). OCS-01 is a high-concentration, topic...

11/24/2021
BreakingGlaucomaStudySurgical
OMNI Glaucoma Procedure Dampens Daily Fluctuations in IOP, Sight Sciences Says
OMNI Glaucoma Procedure Dampens Daily Fluctuations in IOP, Sight Sciences Says

Sight Sciences reported on Nov. 17 that data published in Clinical Ophthalmology show that the OMNI Surgical System for glaucoma suppressed daily fluctuations in intraocular pressure (IOP). OMNI is...

11/24/2021
BreakingGlaucomaRegulationSurgical
Glaukos, Sight Sciences Report New CMS Fees for Glaucoma Procedures
Glaukos, Sight Sciences Report New CMS Fees for Glaucoma Procedures

Glaukos, of San Clemente, California, reported Nov. 4 the 2022 reimbursement fees for minimally invasive glaucoma surgery (MIGS) performed in combination with cataract surgery, published by the Cen...

11/23/2021
AAOMeetingNewsletter
Tepezza, Epi-On Crosslinking Top List of AAO Hot Topics
Tepezza, Epi-On Crosslinking Top List of AAO Hot Topics

Hot topics at the 2021 American Academy of Ophthalmology (AAO) annual meeting and satellite sessions in New Orleans included newly available and up-and-coming technologies, such as Horizon’s Tepezz...

11/24/2021
BreakingClinical TrialGene TherapyRetina
GenSight Provides Updates on RP, LHON Candidates
GenSight Provides Updates on RP, LHON Candidates

Paris-based GenSight Biologics reported Nov. 17 that a second patient with late-stage retinitis pigmentosa (RP) partially recovered visual function after treatment with the company’s GS030 optogene...

11/24/2021
BreakingDealsFunding
Novartis’ Series B Investment in Kedalion Includes Option to Acquire
Novartis’ Series B Investment in Kedalion Includes Option to Acquire

Swiss company Novartis has made an undisclosed Series B investment in Kedalion Therapeutics and signed an exclusive option to acquire agreement with the Menlo Park, California, company, Kedalion an...

11/24/2021
BreakingCataractPharmaRegulation
Amneal Receives Approval for Difluprednate Ophthalmic Emulsion
Amneal Receives Approval for Difluprednate Ophthalmic Emulsion

Amneal Pharmaceuticals announced Nov. 19 that it had received abbreviated new drug application (ANDA) approval from the US FDA for difluprednate ophthalmic emulsion 0.05%, the generic version of Du...

11/24/2021
BreakingFundingGene TherapyRetina
Neurophth Raises More than $60 Million in Series C Financing
Neurophth Raises More than $60 Million in Series C Financing

China’s Neurophth Therapeutics announced Nov. 23 that it had closed a Series C financing round of more than US $60 million. CMG-SDIC Capital and Sequoia Capital China led the round. Neurophth is de...

11/23/2021
EyeceleratorMeetingNewsletter
Pressures on Industry, Clinicians Frame Discussions at Eyecelerator
Pressures on Industry, Clinicians Frame Discussions at Eyecelerator

Cuts in reimbursement and pressures born from COVID-19 drove collaborative discussions between ophthalmic industry officials and clinicians at the latest Eyecelerator meeting, as participants exami...

11/23/2021
AAOMeetingNewsletter
AAO Meeting Evolves Amid Pandemic, Social Unrest, Change in CEOs
AAO Meeting Evolves Amid Pandemic, Social Unrest, Change in CEOs

The American Academy of Ophthalmology has released preliminary attendance figures showing 9,812 people traveled to the 2021 AAO annual meeting. That is less than half of the 20 thousand to 24 thous...

11/23/2021
NewsletterPresbyopiaRegulation
FDA Approval of Allergan’s Vuity Makes Presbyopia Drops a Reality After Years in Making
FDA Approval of Allergan’s Vuity Makes Presbyopia Drops a Reality After Years in Making

Allergan, an AbbVie company, announced Oct. 29 that the US FDA had approved Vuity (pilocarpine HCl ophthalmic solution) 1.25% for the treatment of presbyopia in adults. Vuity is the first and only ...

11/23/2021
NewsletterRegulationRetina
FDA Approves Xipere for Suprachoroidal Use in ME with Uveitis
FDA Approves Xipere for Suprachoroidal Use in ME with Uveitis

Bausch + Lomb and Clearside Biomedical announced Oct. 25 that the US FDA had approved Xipere (triamcinolone acetonide injectable suspension) for suprachoroidal use for the treatment of macular edem...

Past News Stories

11/23/2021
AcquisitionsGlaucomaNewsletter
Alcon Acquires Ivantis for $475 Million, Plus Potential Milestone Payments
Alcon Acquires Ivantis for $475 Million, Plus Potential Milestone Payments

Alcon has bolstered its glaucoma surgical device portfolio with the acquisition of Ivantis and its Hydrus Microstent. Alcon, a Switzerland-registered company with US headquarters in Texas, announce...

11/23/2021
NewsletterPharmaSurgical
Johnson & Johnson to Spin off Consumer Health Division in 2023
Johnson & Johnson to Spin off Consumer Health Division in 2023

Johnson & Johnson plans to spin off its consumer health division from its stronger pharmaceutical and device businesses, the company announced Nov. 12. The name will remain with the drug and device...

11/23/2021
IOLNewsletterRegulation
Oculentis Reports Bankruptcy as Legal Challenges Mount Over Former Lenses Clouding
Oculentis Reports Bankruptcy as Legal Challenges Mount Over Former Lenses Clouding

Intraocular lens maker Oculentis is in bankruptcy proceedings, according to an announcement posted on its website in Q3-2021. The Netherlands-based company, headquartered in Germany until 2019, app...

11/23/2021
NewsletterRegulation
Select US FDA Approvals and Clearances in October 2021
Select US FDA Approvals and Clearances in October 2021

The US FDA granted one clearance through the ophthalmic device division using the 510(k) pathway in October 2021, according to the agency’s database. Notably, New World Medical gained clearance for...

11/23/2021
GlaucomaNewsletterRegulation
iSTAR’s MINIject Glaucoma Implant Receives European Market Approval
iSTAR’s MINIject Glaucoma Implant Receives European Market Approval

Belgium’s iSTAR Medical announced Nov. 17 that its MINIject minimally invasive glaucoma surgery (MIGS) implant had received marketing approval in Europe for open-angle glaucoma. The MINIject is imp...

11/23/2021
GlaucomaNewsletterRegulation
Glaukos, Sight Sciences Report New CMS Fees for Glaucoma Procedures
Glaukos, Sight Sciences Report New CMS Fees for Glaucoma Procedures

Glaukos, of San Clemente, California, reported Nov. 4 the 2022 reimbursement fees for minimally invasive glaucoma surgery (MIGS) performed in combination with cataract surgery, published by the Cen...

11/23/2021
NewsletterRegulation
Medicare Advantage Patients Warned of Prior Authorization, Step Therapy Clauses
Medicare Advantage Patients Warned  of Prior Authorization, Step Therapy Clauses

The American Academy of Ophthalmology (AAO) and American Society of Cataract and Refractive Surgery (ASCRS) are urging Medicare patients to carefully review their Medicare Advantage plans for two p...

11/23/2021
DiagnosticDry EyeFundingGene TherapyLaserNewsletterRetina
Novartis Leads Latest Fundraising with $20.7 Billion Roche Share Buyback
Novartis Leads Latest Fundraising with $20.7 Billion Roche Share Buyback

Swiss company Novartis led recent fundraising efforts by ophthalmic companies, thanks to Roche repurchasing 53.3 million shares held by Novartis for $20.7 billion. Funding for the past four weeks t...

11/23/2021
AAOMeetingNewsletter
Nearly 300 Ophthalmic Companies Exhibit at the 2021 AAO Meeting
Nearly 300 Ophthalmic Companies Exhibit at the 2021 AAO Meeting

The American Academy of Ophthalmology said its 2021 annual meeting featured 295 exhibiting companies and organizations. Preliminary attendance figures released Nov. 17 indicated that 4,351 individu...

11/23/2021
AAOCataractIOLMeetingNewsletterRefractiveSurgical
AAO PC-IOL Sessions Look at Lens Selection, Attendees’ Own Choices, Status of Post-LVC Eyes
AAO PC-IOL Sessions Look at Lens Selection, Attendees’ Own Choices, Status of Post-LVC Eyes

The topic of choosing the best presbyopia-correcting intraocular lens (PC-IOL) for cataract patients seeking independence from glasses—including eye surgeons and ophthalmic industry participants th...

11/23/2021
AAOMeetingNewsletterRetina
Susvimo Grabs the Spotlight in Retina at 2021 AAO Meeting
Susvimo Grabs the Spotlight in Retina at 2021 AAO Meeting

A sustained drug-delivery device, potential new trial endpoints, and access to a cheap drug grabbed the attention of retina specialists at the 2021 meeting of the American Academy of Ophthalmology ...

11/23/2021
AAODeviceGlaucomaMeetingNewsletterSurgical
2021 AAO Glaucoma Sessions Discuss Lack of Surgical Options for Advanced Patients, Exciting Tech on Horizon
2021 AAO Glaucoma Sessions Discuss Lack  of Surgical Options for Advanced Patients, Exciting Tech on Horizon

Kuldev Singh, MD, told attendees at the 2021 meeting of the American Academy of Ophthalmology that the biggest gap in glaucoma surgery today is the need for safer and more effective procedures for ...

Want to Read the Full Article?

Register A Corporate Account

A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.

Select one or more
Select one or more